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AbstrACt
Introduction Perioperative complications have a lasting 
effect on health-related quality of life and long-term 
survival. The Royal College of Anaesthetists has proposed 
the development of perioperative medicine (POM) services 
as an intervention aimed at improving postoperative 
outcome, by providing better coordinated care for high-risk 
patients. The Perioperative Medicine Service for High-risk 
Patients Implementation Pilot was developed to determine 
if a specialist POM service is able to reduce postoperative 
morbidity, failure to rescue, mortality and cost associated 
with hospital admission. The service involves individualised 
objective risk assessment, admission to a postoperative 
critical care unit and follow-up on the surgical ward by the 
POM team. This paper introduces the service and how it 
will be evaluated.
Methods and analysis of the evaluation A mixed-
methods evaluation is exploring the impact of the service. 
Clinical effectiveness of the service is being analysed 
using a ‘before and after’ comparison of the primary 
outcome (the PostOperative Morbidity Score). Secondary 
outcomes will include length of stay, validated surveys 
to explore quality of life (EQ-5D) and quality of recovery 
(Quality of Recovery-15 Score). The impact on costs is 
being analysed using ‘before and after’ data from the 
Patient-Level Information and Costing System and the 
National Schedule of Reference Costs. The perceptions and 
experiences of staff and patients with the service, and how 
it is being implemented, are being explored by a qualitative 
process evaluation.
Ethics and dissemination The study was classified as 
a service evaluation. Participant information sheets and 
consent forms have been developed for the interviews 
and approvals required for the use of the validated 
surveys were obtained. The findings of the evaluation are 
being used formatively, to make changes in the service 
throughout implementation. The findings will also be used 
to inform the potential roll-out of the service to other sites.
IntroduCtIon 
In the UK, an estimated 10 million proce-
dures occur per year, and worldwide, this 
figure stands at 313 million per annum.1 
Mortality varies between patient populations, 
depending on patient characteristics, the type 
and urgency of surgery undertaken, and the 
quality of care delivered. Estimates of short-
term mortality after major surgery (defined as 
surgery which requires an inpatient hospital 
stay) currently stand at around 0.5%–1%; 
however, serious postoperative complica-
tions (or morbidity) occur in around 15% of 
such patients.2 Such complications can have 
a lasting effect on health-related quality of 
life and long-term survival.3–6 National guid-
ance recommends various approaches to the 
management of surgical patients considered 
to be at high risk of death or major complica-
tions.7 However, audit and research data show 
that compliance with many of the recom-
mended processes is low.8 9 
A significant amount of resource is invested 
in the intraoperative care of patients under-
going major surgery, and relatively little 
is allocated to their postoperative care by 
strengths and limitations of this study
 ► Perioperative Medicine Service for High-risk 
Patients Implementation Pilot is the first pilot of a 
perioperative medicine service using a team com-
prising anaesthesia and intensive care trainees. The 
concurrent robust mixed-methods evaluation will 
therefore explore important questions regarding po-
tential future models of working.
 ► The evaluation is based on a controlled before and 
after research design and a qualitative process eval-
uation, thus capturing different aspects of the out-
comes and implementation of the service.
 ► The implementation of the service and evaluation 
are taking place in one site, thus limiting the gener-
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comparison. Bundled payments for surgery in the UK 
reward increased activity (more surgery, more outpatient 
appointments) and neglect the role of postoperative care 
of inpatients. The Royal College of Anaesthetists has 
proposed the development of perioperative medicine 
(POM) services as an intervention aimed at improving 
postoperative outcome, by providing better coordinated 
care for high-risk patients. An overall strategy has been 
developed and published10; however, detailed plans for 
the implementation of POM services have not yet been 
developed or tested.
One underpinning theory of change for POM services 
proposes that if high-risk patients are identified before 
surgery (through individualised risk stratification), and 
then monitored with appropriate vigilance and provided 
extra support throughout their perioperative pathway, that 
deterioration can be predicted and possibly prevented. 
An important supporting mechanism for this comes 
from the literature surrounding the concept of ‘failure to 
rescue’, which uses data from the USA to show that while 
risk-adjusted complication rates may vary two or three-
fold between different institutions, risk-adjusted mortality 
rates after developing complications can vary more than 
10-fold.11 12 This implies that system-level differences in 
structure and process are influencing surgical outcome, 
more than the individual skills of the operating surgeon, 
surgery staff or anaesthesia teams. Further research from 
the USA has explored the role of communication, team 
working and safety culture in the avoidance of ‘failure to 
rescue’.13 14
We hypothesise that the implementation of a POM 
service for the care of high-risk surgical patients will 
reduce postoperative morbidity, failure to rescue, 
mortality and cost associated with hospital admission. 
The implementation pilot comprises two elements: the 
new patient-facing service and its concurrent evaluation. 
Data collection commenced in February 2016 and will 
continue until August 2018, with an expected recruit-
ment of 2000 patients.
the new service
The Perioperative Medicine Service for High-risk 
Patients Implementation Pilot (POMSHIP) will run 
at University College Hospital at Westmoreland Street 
from May 2016 to August 2018. This is a satellite hospital 
performing only scheduled thoracic and urological 
surgery. The service comprises three main components 
(summarised in figure 1).
1. Individualised preoperative risk assessment of all eli-
gible patients by the POM team. We are using a com-
bination of risk-prediction tools which have been 
individually validated (see the Recruitment section) 
for organ-specific morbidity, global postoperative com-
plications or mortality. Patients scoring as high risk in 
any of these assessment methods will be recruited into 
the pathway and receive the second two components 
of the service.
2. Postoperative admission to a critical care unit. This is a 
recommended standard of care for patients considered 
high risk of perioperative complications, but there is 
disagreement over the thresholds which should be 
used to trigger admission.15
3. Ward-based postoperative follow-up by a POM team 
member until fit for discharge from hospital. The 
POM team will be staffed by senior trainees in anaes-
thesia, supported by intensive care consultants. A POM 
service consisting of geriatricians was shown to be 
beneficial in the urology population,16 but we are not 
aware of any previous trials of POM services delivered 
by anaesthesia and intensive care trainees.
Inclusion criteria for study population
The study population is determined on the basis of risk 
factors which have been previously associated with high 
perioperative risk, namely: surgical magnitude, age and 
comorbidities. Inclusion criteria for the study population 
are presented in table 1.
All patients, who fulfil eligibility criteria on the basis of 
screening of type of surgery, comorbidities and age, will be 
assessed for inclusion in the POMSHIP pathway through 
risk assessment (as described below) in the preoperative 
assessment clinic.
Exclusion criteria
Surgical patients with an expected length of stay (LOS) 
less than two nights. Any patient who becomes ‘of 
concern’ to ward staff while in hospital can be referred to 
the POM team for an opinion, but these patients will not 
be included in the analysis if they have not received the 
complete POMSHIP service.
Recruitment to POMSHIP
Most of the patients on this site are undergoing expe-
dited cancer surgery. They are referred to the preoper-
ative anaesthetic assessment nurse-led clinic at the time 
of decision to operate. They would normally be preas-
sessed and operated on within 30 days. All patients who 
are deemed eligible according to the inclusion/exclusion 
criteria described above are referred to the POM team 
by the preassessment nurses and will undergo an indi-
vidualised objective risk assessment as described below. 
Those patients, who meet the criteria of ANY individual 
risk-prediction score or whom the POM team suspect 
have risks not captured by the risk-prediction tools, will 
be included in POMSHIP. Multiple risk assessment tools 
will be used to ensure we detect as many high-risk patients 
as possible, to allow for variation in their accuracy and for 
the purposes of risk adjustment in our subsequent anal-
ysis. Where the POM team feel the calculated risks are 
underestimated, they may use their discretion to deem 
the patient high risk.
Individualised risk assessment
Patients referred to the POM team undergo individual-
ised risk assessment using eight previously published risk 
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preoperative assessment with nursing staff. These risk assess-
ment tools were selected by reviewing the literature to find 
tools validated for common or important postoperative 
complications.
Four validated tools which predict organ-specific 
complications were found and are being used with 
thresholds for referral into the POMSHIP postoperative 
pathway as described below:
 ► Postoperative acute kidney injury has been shown to 
be predicted by the American College of Surgeons’ 
National Surgical Quality Improvement Program 
acute kidney injury risk score.17 A class ≥3 or other 
risk factors (as identified by the UK’s National 
Institute for Health and Care Excellence (NICE)—
namely exposure to contrast or nephrotoxic drugs) 
is the threshold to refer patients into the POMSHIP 
pathway.
 ► Lee’s Revised Cardiac Risk Index is a validated and 
well-established tool for estimating perioperative risk 
of major adverse cardiac events.18 19 The presence 
Figure 1 Diagram of the POMSHIP pathway. AKI, Acute Kidney Injury; ARISCAT, Assess Respiratory Risk in Surgical 
Patients in Catalonia; ASA,  American Society of Anesthesiologist's Physical Statust Score; DASI, Duke Activity Status Index; 
EFS, Edmonton Frail Scale; NSQIP, National Surgical Quality Improvement Program; PACU, Post-Anaesthetic Care Unit; POD, 
postoperative delirium; POM, perioperative medicine; POMSHOP, Perioperative Medicine Service for High-Risk Patients 
Implementation Pilot; RCRI, Revised Cardiac Risk Index; VATS, Video-Assisted Thoracoscopic Surgery.
Table 1 Inclusion criteria for study population
Criteria Description
Surgical magnitude Any urological surgical patient undergoing cystectomy, Mitrofanoff procedure; formation of 
neobladder, nephrectomy or any urological surgical procedure involving a laparotomy; any thoracic 
surgical patient undergoing lobectomy (VATS or open), pneumonectomy, thoracotomy, mediastinal 
tumour resection or any thoracic procedure involving a sternotomy.
Or




Any patient with ASA grade ≥3 (or with comorbidities causing concern to the preassessment team) 
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of two or more risk factors triggers inclusion in the 
POMSHIP pathway.
 ► The Assess Respiratory Risk in Surgical Patients in 
Catalonia model has been externally validated for 
predicting postoperative pulmonary complications.20 
A score ≥45 denotes ‘high risk’ and therefore entry to 
the POMSHIP pathway.
 ► Postoperative delirium (POD) is a common compli-
cation in the older surgical population. The Amer-
ican Geriatrics Society include risk assessment 
criteria within their guidelines for best practice in 
the management of POD.21 NICE has also published 
guidelines and a list of recognised risk factors for 
developing delirium in hospital (not specifically post-
operatively).22 If a patient scores two or more risk 
factors sourced from the predictors in one or both 
sets of guidelines, they are deemed to be at high risk 
for POD and therefore referred onto the POMSHIP 
pathway.
Additionally, four risk prediction tools have been 
identified as validated ways of predicting overall patient 
outcome:
 ► The Surgical Outcome Risk Tool (SORT) is a UK-de-
veloped and internally validated, parsimonious risk 
assessment tool for 30-day mortality.23 A predicted 
mortality ≥1% has been chosen as the entry criteria 
to the pathway.
 ► The Edmonton Frail Scale is an objective measure 
of frailty which has been validated as predictive of 
postoperative complications.24 25 A score ≥8 has been 
chosen as the referral trigger to POMSHIP as this was 
shown to reflect a higher risk of complications and a 
lower risk of being discharged home.
 ► Functional capacity has been repeatedly shown to 
correlate well with perioperative mortality and with 
risk of major adverse cardiovascular events. The Duke 
Activity Status Index can be used to record patient-re-
ported functional capacity in metabolic equivalents.26 
A score <4 is indicative of high risk and triggers inclu-
sion in POMSHIP.
 ► Cardiopulmonary exercise testing (CPET) has 
been found to be predictive of outcome in patients 
having intra-abdominal surgery.27 An anaerobic 
threshold <11 mL/kg/min were found to be predic-
tive of postoperative complications and will therefore 
trigger inclusion in POMSHIP. Referral for CPET is 
decided by the regular preassessment team and results 
considered by the POM team only if available.
Postoperative critical care admission
All patients determined to be high risk on the basis of the 
above screening criteria are booked for admission to the 
postoperative anaesthetic care unit (PACU). This unit cares 
for levels 2–3 patients, is staffed by intensive care doctors 
and nurses (under the supervision of an on-site intensive 
care consultant) and aims to provide 24 hours of high inten-
sity care in the immediate postoperative period. The PACU 
was established in 2001, providing postoperative levels 2–3 
support for cardiothoracic surgical patients. In 2015, there 
was a reorganisation of services and urology and thoracic 
surgery moved to the Westmoreland Street site. The main 
goals of PACU admission are to optimise pain manage-
ment, mobilise early and return to oral intake, and careful 
attention to fluid management. There are no specific proto-
cols regarding goal-directed haemodynamic optimisation 
although devices such as the oesophageal Doppler which 
facilitate this type of therapy are available should the clinical 
team decide it to be necessary. Standard discharge practices 
based on Trust protocols will be used for all patients, regard-
less of whether they are in the POMSHIP pathway: review by 
the PACU Consultant prior to discharge to the ward; return 
to preoperative physiological parameters with no ongoing 
requirement for organ support greater than 4L/min oxygen 
therapy; all critical care only medication discontinued; acute 
pain score less than two for two consecutive hours.
Ward-based postoperative follow-up
Post-PACU discharge, patients are followed up by the 
POM team which comprises senior trainees in anaesthesia 
and/or intensive care with clinical support from intensive 
care consultants. This is a novel intervention aiming to 
avoid the phenomenon of ‘failure to rescue’, as described 
above.11 12 It has a number of discrete objectives:
 ► Thorough clinical assessment to identify signs of post-
operative deterioration early in the patients’ postop-
erative course.
 ► To recommend clinical actions to the parent surgical 
team with the intention of instituting interventions to 
prevent clinical deterioration and ‘failure to rescue’.
 ► Surveillance of existing complications and the coor-
dination of communications between the multidisci-
plinary team.
 ► To facilitate the readmission of patients to critical care 
when deemed necessary.
All POMSHIP patients receive daily clinical follow-up on 
the postoperative wards until discharge. This process has 
been structured and developed into a protocol to mini-
mise variations in practice and to enable the delivery of 
consistent, high-quality care. Clinical assessment takes the 
form of clinical examination and case note review. Once 
clinical reviews of all patients have been completed, the 
clinical fellow liaises with the POM/PACU consultant to 
discuss all recommendations to be communicated to the 
parent team. Following this discussion, a consultant ward 
round is conducted of relevant patients. All POMSHIP 
patients will have a daily POM review until discharge. 
When patients are fit for medical discharge from hospital 
but remain admitted for non-medical reasons, a ‘fit for 
discharge’ box on the daily review proforma will be ticked.
MEthods And AnAlysIs
Aim
To evaluate the implementation and impact of the new 
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objectives
1. To evaluate clinical effectiveness (morbidity, health-re-
lated quality of life and ‘failure to rescue’) of this 
pathway.
2. To analyse and compare admission-associated costs 
before and after implementation and estimate the 
cost-effectiveness of the new service.
3. To explore staff and patient beliefs, attitudes and 
behaviours before and after implementation of the 
service.
study design
This study evaluates the impact of the new POM service 
using a mixed-methods approach comprising three 
elements:
Clinical effectiveness
We will evaluate the impact of the POM service on patient 
outcomes using a ‘before and after’ analysis. The primary 
outcome is the presence of morbidity on postoperative 
day 7, as measured using the PostOperative Morbidity 
Survey (POMS). A previously validated and widely used 
instrument, the POMS captures morbidity of sufficient 
magnitude to require inpatient care.28 Prolonged post-
operative morbidity, defined using the POMS, has been 
associated with reduced long-term survival.4 Secondary 
outcomes include: length of postoperative hospital stay 
(LOS); POMS morbidity on day 3 and 14; unplanned 
admission to critical care; unplanned return to the oper-
ating theatre; inpatient mortality and ‘failure to rescue’ 
defined as the proportion of patients who die in hospital 
after developing complications (inpatient mortality 
occurring after POMS morbidity on day 7). Patient-re-
ported outcomes are being collected, including: the 
Quality of Recovery-15 (QoR-15) Score,29 measured at 
baseline (preoperatively) and on day 3 after surgery and 
the EQ-5D (a quality of life metric) measured at baseline 
and at 6 months postoperatively.30
Costs and cost-effectiveness
We will undertake a ‘before and after’ cost analysis using 
data from 3 months preimplementation and 3 months 
postimplementation. If the service is shown to be clini-
cally effective then a ‘before and after’ cost-effectiveness 
analysis will be conducted using EQ-5D to reflect quality 
of life.
Qualitative process evaluation
In-depth qualitative studies have been increasingly 
recognised as valuable evaluations of complex healthcare 
interventions.31 We have been interviewing and observing 
staff to help understand their perceptions and experi-
ences with the POM service. Data are being collected in 
two waves: first at baseline and during a follow-up period 
after launch of the new service. Additionally, a sample 
of patients recruited to the pathway is being interviewed 
during the follow-up period to gather their experiences 
of the POM service. The qualitative data will be subjected 
to framework analysis to elucidate staff and patient views 
of: the strengths and weaknesses of the existing system; 
the benefits and risks of the new service; the barriers and 
enablers to implementation of the new service and the 
potential for sustainability and spread of the new service. 
Findings from this element of the evaluation will be fed 
back formatively to the POM team to enable iterative 
adaptation of implementation strategy.
Quantitative and health economic data collection
Evaluation of clinical effectiveness
Data collection began in February 2016, 3 months before 
implementation of the service in May 2016. Objective risk 
factors for adverse outcomes are being collected from 
patients’ health records by the POM team and research 
nurses. These include the variables within the Ports-
mouth-Physiological and Operative Severity Score for the 
Enumeration of Mortality and Morbidity (P-POSSUM),32 
the most widely validated risk adjustment model for 
heterogeneous surgical cohorts and the SORT.23 The 
patient-reported outcome measures are being collected 
by a member of the POM team at baseline (preopera-
tively) and in hospital on day 3 after surgery (QoR-15). 
Patients are being contacted by email or telephone to 
collect the 6-month EQ-5D data.
Evaluation of costs
Resource use and costs will be determined using: the 
upfront cost of staffing the service, Patient-Level Infor-
mation and Costing System data provided by the Trust 
finance department and the National Health Service 
National Schedule of Reference costs. Using a diary-mon-
itoring exercise, we will calculate the extra staff time 
required per patient to provide a POM service such as the 
model we describe.
Qualitative data collection
Evaluation of staff and patients’ perceptions and experiences of 
the new service
Data are being gathered during two waves of semistruc-
tured interviews and non-participant observation of staff 
meetings: the first wave will be conducted at baseline 
and the second wave will begin approximately 4 months 
after implementation. Interview topic guides are being 
used to explore topics such as: perceived strengths/weak-
nesses of the baseline system; knowledge, expectations 
and experiences of the new service; perceived barriers/
enablers of implementation; perceived transferability of 
the new service (the full topic guides are presented in 
online supplementary appendices 1–3).
Interviews are being conducted by an anaesthetic regis-
trar (DuW) as part of his academic clinical fellowship 
training, under the guidance of experienced qualitative 
researchers (CV-P). He has previously worked at the Trust 
(at a different site) and so may know some of the staff 
being interviewed.
Interviews are being conducted in private and last 
approximately 30–60 min. They are being audio recorded 
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researcher is writing a memo reflecting on what was 
learnt.
A sample (using the sampling strategy defined below) 
of patients is being approached for recruitment during 
the second wave of data collection. The interviews are 
semistructured. The interview topic guide is presented 
in the online supplementary appendix 3. Interviews are 
conducted in private and last approximately 30–60 min. 
The interviews are audio-recorded and professionally.
Relevant meetings for observation are being identified 
by discussion with local stakeholders. A Structured Obser-
vation guide (see online supplementary appendix 4) is 
being used to record field notes at the meetings. After 
each meeting, the researcher is writing a memo reflecting 
on what was learnt. Data collection from meetings is being 
regarded as complete when a substantial and full account 
of the issues has been generated such that a rich depth of 
material has been generated for analysis.
Sampling of staff and patients for interviews
Purposive sampling across professional groups is being 
used to ensure representation of all major groups of 
stakeholders in staff interviews. These groups include: 
preassessment nurses and doctors; urology and thoracic 
surgeons (consultants, registrars and junior doctors); 
urology and thoracic ward nurses and clinical nurse 
specialists; anaesthetists and intensivists; allied health 
professionals (eg, physiotherapists, pharmacists, dieti-
cians); the acute pain team; ICU outreach nurses and 
general managers. There are two waves of interviews with 
staff members, including a maximum of 15 staff members 
per wave. The research is aiming to interview the same 
participants during both waves of data collection.
Once the second wave of data collection began, patients 
on the new pathway have been continuously sampled for 
interview until theoretical saturation is achieved (this 
is likely to occur with 10–15 participants). Patients are 
being identified from existing POMSHIP inclusion data. 
Urology and thoracic surgery patients are being recruited 
in similar numbers.
Recruitment for interviews
Staff members of relevant teams are being approached 
by the researcher to see if they would like to receive 
further information about the study. This information is 
sent to them through the hospital internal email system 
48 hours before any interview and includes a staff partic-
ipant information sheet and a staff informed consent 
form. The researcher follows up the email invitation 
with a face-to-face approach, allowing questions to be 
answered and interest to be confirmed. The PIS includes 
contact information for the chief investigator (CI) and 
principal investigator (PI) should any further informa-
tion be required. Interviewees are selected according to 
the sampling strategy described above. If the interviewee 
agrees to take part in the interview, they are asked to sign 
a consent form.
Patients are approached in person by the researcher on 
the postoperative surgical ward, have the study explained 
to them and given the patient information sheet and 
consent form. They are allowed at least 24 hours to 
consider their decision to take part in the study. The 
patient information sheet includes contact information 
for the CI and PI, should any further information be 
required. Patients are selected according to the sampling 
strategy described above.
Relevant meetings for observation are identified 
through discussion with local staff members. Before 
attending meetings, the researcher contacts and seeks 
permission to attend from the meeting Chair. A PIS is 
circulated to all participants 48 hours before the meeting 
along with routine papers. The PIS is also available at the 
beginning of the meeting when participants are given 
the opportunity to opt-out of having their contributions 
recorded should they so wish.
data analysis
Evaluation of clinical effectiveness
We will evaluate the impact of the POM service on patient 
outcomes using a ‘before and after’ analysis. Logistic 
(or in the case of LOS, linear) regression will be used to 
account for potential confounders, with variable selection 
based on the P-POSSUM and SORT models, and indi-
vidual variables selected on the basis of forward stepwise 
regression, dropping variables with p>0.1. In order to 
prevent overfitting of the risk model, variables with inci-
dence <1% in the population will be excluded. The final 
model will provide a predicted likelihood (risk score) of 
the outcome of interest (day 7 POMS morbidity) for each 
patient. These risk scores will then be used as covariates 
(defining patient risk) in a multilevel regression model. 
Comparison will be made for risk-adjusted population 
outcomes (incidence of day 7 POMS morbidity) before 
and after implementation of the pathway; thus, the ‘after’ 
group will include patients within the study population 
who were screened but not subsequently selected for 
inclusion in the POMSHIP pathway based on the results 
of their risk assessment. Outcomes will be compared 
between patients before and after implementation of 
POMSHIP, and also between those receiving and not 
receiving the POMSHIP intervention. Data collected in 
the 6 months after cessation of the service will also be 
analysed.
Evaluation of costs
Similar to clinical outcomes, we will undertake a ‘before 
and after’ analysis for costs, presenting the total differ-
ence before versus after, as well as the relative cost per 
patient and per spell. Univariate sensitivity analyses will be 
conducted on incidence of morbidity and mortality, costs 
of treatment and investigations, length of total hospital 
stay, and number of (re)admissions to critical care. These 
factors will be investigated to examine their effect on the 
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Evaluation of staff and patient perceptions and experiences of the 
new service
The interview transcripts and observation notes will be 
subjected to framework analysis.33 Framework analysis 
allows systematic and comprehensive review of material 
collected, and between and within-case analysis.34 35 The 
data will be analysed according to the themes identified 
in the research objectives and will also include additional 
themes that emerge from the collected data. A code-
book will be developed to maintain consistency in the 
coding and to carry out triangulation of interview and 
observation data. Qualitative data will be analysed using 
NVivo (QSR International V.10, 2014). Two researchers 
will compare a sample of transcripts to check the coding 
strategy. Findings will be shared with interview partici-
pants to check accuracy.
Integrating findings
Qualitative findings from the interviews with, and obser-
vations of, staff and patients will be formatively fed back 
to the POM team to enable iterative adaptation of their 
implementation strategy.
PAtIEnt And PublIC InvolvEMEnt
This research addresses the following priorities identified 
by the James Lind Alliance Priority Setting Partnerships: 
anaesthesia/perioperative care, intensive care, dementia 
and pressure ulcers.
We are grateful for feedback on the interview topic guide 
and structured observation guide from the Embedded 
Research Team Patient and Public Involvement Panel at 
the Department of Applied Health Research, UCL.
A draft manuscript detailing the results of this study will 
be circulated to all participants involved in the qualita-
tive research, including patients, giving them an opportu-
nity to feedback any comments for inclusion in the final 
manuscript which we aim to publish in a peer-reviewed 
journal.
EthICs And dIssEMInAtIon
Permission was granted by EuroQOL to use the EQ-5D 
in our evaluation. Patients will be asked to sign a consent 
form stating that they were happy to be contacted by 
email or telephone to be asked EQ-5D questions after 
leaving hospital. Patients and staff will be asked to sign 
consent forms to record their interviews.
dissemination
Findings are being shared with the POM team so processes 
and pathways can be reviewed and refined throughout 
the implementation. Manuscripts detailing the quan-
titative and qualitative evaluations will be submitted to 
peer-reviewed journals for publication. Presentations will 
be prepared for professional and lay audiences.
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